Kunihiko Umekita
Overview
Explore the profile of Kunihiko Umekita including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
234
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kimura M, Umekita K, Iwao C, Kawano K, Hashikura Y, Hashiba Y, et al.
Front Immunol
. 2024 Nov;
15:1480506.
PMID: 39534598
Background: T-SPOT.TB, one of the screening tests for latent tuberculosis infection (LTBI), yields invalid results in human T-cell leukemia virus type 1 (HTLV-1)-positive patients with rheumatoid arthritis. However, the detailed...
2.
Kawaguchi T, Kitamura A, Kimura M, Rikitake Y, Iwao C, Iwao K, et al.
J Infect Chemother
. 2024 Oct;
31(1):102534.
PMID: 39378977
Treating disseminated cryptococcosis in people with human immunodeficiency virus (HIV) is challenging due to the limited availability of effective antifungals. Although isavuconazole has antifungal activity against Cryptococcus neoformans, clinical evidence...
3.
Tominaga M, Uto T, Fukaya T, Mitoma S, Riethmacher D, Umekita K, et al.
Front Immunol
. 2024 Aug;
15:1200461.
PMID: 39206204
Dendritic cells (DCs) are known as unique professional antigen (Ag)-presenting cells (APCs) to prime naïve T cells for the initiation of adaptive immunity. While DCs are believed to play a...
4.
Kawaguchi T, Matsuda M, Umekita K, Miyazaki T
Respirol Case Rep
. 2024 Jul;
12(7):e01428.
PMID: 38983609
Nintedanib has been demonstrated to inhibit the rate of forced vital capacity decline in patients with progressive fibrosing interstitial lung diseases (PF-ILD) at a dose of 200 or 300 mg/day...
5.
Mekata H, Yamada K, Umeki K, Yamamoto M, Ochi A, Umekita K, et al.
BMC Vet Res
. 2024 May;
20(1):190.
PMID: 38734647
Severe fever with thrombocytopenia syndrome (SFTS) is a fatal zoonosis caused by ticks in East Asia. As SFTS virus (SFTSV) is maintained between wildlife and ticks, seroepidemiological studies in wildlife...
6.
Kawaguchi T, Rikitake Y, Rikitake M, Kimura M, Iwao C, Iwao K, et al.
J Infect Chemother
. 2024 Apr;
30(12):1309-1314.
PMID: 38574814
Human granulocytic anaplasmosis (HGA) is a tick-borne infection caused by Anaplasma phagocytophilum. Only seven cases of HGA have been reported in Japan to date. We report the case of a...
7.
Kawano K, Hashikura Y, Umekita K
Viruses
. 2024 Feb;
16(2).
PMID: 38400025
To mediate intercellular communication, cells produce extracellular vesicles (EVs). These EVs transport many biomolecules such as proteins, nucleic acids, and lipids between cells and regulate pathophysiological actions in the recipient...
8.
Horiguchi T, Sumiyoshi M, Nagatomo E, Sakamoto K, Ogawa S, Ichinari N, et al.
BMC Infect Dis
. 2023 Dec;
23(1):863.
PMID: 38062360
Background: Luteibacter jiangsuensis is a gram-negative aerobic bacillus that was first isolated from soil samples at a pesticide factory in China and reported in 2011. Here, we describe the first...
9.
Kudo R, Kawaguchi T, Kimura M, Rikitake Y, Iwao C, Rikitake M, et al.
Heliyon
. 2023 Dec;
9(11):e22221.
PMID: 38045178
Various diseases (e.g., hypertension and diabetes) are risk factors for the exacerbation of coronavirus 2019 (COVID-19). Patients with chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD) tend to...
10.
Kuramitsu M, Momose H, Uchida Y, Ishitsuka K, Kubota R, Tokunaga M, et al.
Microbiol Spectr
. 2023 Nov;
11(6):e0207823.
PMID: 37966220
The World Health Organization estimated that 5-10 million people are infected with human T-cell leukemia virus type 1 (HTLV-1). This number is likely to be underestimated because reliable endemic data...